Viking Therapeutics Inc. (VKTX)

13.83 -0.61 (-4.224%)

IEX Real-Time Price

October 19, 2018 EST.

NASDAQ Capital Market : Healthcare

Prev Close 14.44

Price Open 14.52

Volume: 2.44M

Avg Volume: 6.26M

Market Cap: 838.9M

P/E Ratio -23.44

52 Wk Range 2.0801-24



VKTX Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-09-28
57.98M
15.36M
2.36
26.49%

2018-09-14
57.98M
10.45M
4.87
18.03%

2018-08-31
57.98M
9.93M
5.34
17.12%

2018-08-15
57.98M
10.49M
6.13
18.10%




VKTX Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-08-09
Q2 2018
AMC
-0.11 (6)
-0.13
-0.02

2018-05-09
Q1 2018
N/A
-0.11 (3)
-0.10
0.01

2018-03-20
Q4 2017
N/A
-0.19 (3)
-0.10
0.01

2018-03-07
Q4 2017
AMC
-0.19 (3)
-0.10
0.01

News

Biotech Stocks Bloodied But Can Now Drive M&A (2018-10-19 12:04 SeekingAlpha)

The precipitous, waterfall-like, decline in indexes this month was led by the sliding small-cap and biotech indexes. The chart below shows the anatomy of the pullback during the first half of October. The lowest two lines are the biotech indexes. The October Fall - Oct 01 to 12Source: Y…

 

Viking Therapeutics: A Valuation (2018-10-19 10:49 SeekingAlpha)

Valuation spreadsheet Viking Therapeutics ( VKTX ) stock showed tremendous growth as it gained nearly 580 percent in the past 12 months. The stock mainly moved through strong trial results; however, the company also boasts of a robust product pipeline which may be helpful in sustaining the…

 


Statistics

Shares Outstanding: 60.66M

Top 15 Institution Percent: 58.70

Price To Sales: N/A

Price To Book: 6.38

Revenue: N/A

Gross Profit: N/A

Cash: 9.84M

Debt: N/A

Return On Assets: -25.70

Return On Equity: -27.77

Profit Margin: N/A

Price History

Beta: 2.90

50-day Moving Avg: 13.55

200-day Moving Avg: 8.53

YTD Change: N/A

5-day Change: -0.14

1-month Change: -25.80

3-month Change: 44.40

6-month Change: N/A

1-year Change: N/A

Revenue Per Share: 0.00

Revenue Per Employee: 0.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Viking Therapeutics Inc.

Exchange: NASDAQ Capital Market

Industry: Biotechnology

Sector: Healthcare

Website: http://www.vikingtherapeutics.com

Viking Therapeutics Inc is a clinical-stage biopharmaceutical company. The company develops therapies for metabolic and endocrine disorders. It includes portfolio of five drug candidates in clinical trials or preclinical studies.